Evidence map›Paper›PMID 31332511›Full record

ArticleWorld journal of urology2020

Correction to: Unintended consequences of decreased PSA-based prostate cancer screening.

Thomas Ahlering, Linda My Huynh, Kamaljot S Kaler, Stephen Williams, Kathryn Osann, Jean Joseph, David Lee, John W Davis, Ronney Abaza, Jihad Kaouk and 4 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 1 country.

Thomas AhleringDepartment of Urology, University of California, Irvine Health, 333 City Blvd West, Suite 2100, Orange, CA, 92868, USA. tahlerin@uci.edu.
Linda My HuynhDepartment of Urology, University of California, Irvine Health, 333 City Blvd West, Suite 2100, Orange, CA, 92868, USA.
Kamaljot S KalerDepartment of Urology, University of California, Irvine Health, 333 City Blvd West, Suite 2100, Orange, CA, 92868, USA.
Stephen WilliamsDivision of Urology, Department of Surgery, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Kathryn OsannDivision of Hematology-Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, USA.
Jean JosephDepartment of Urology, University of Rochester, Rochester, NY, USA.
David LeePerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
John W DavisUT MD Anderson Cancer Center, Houston, TX, USA.
Ronney AbazaDepartment of Urology, Ohio Health Robotic Urologic Surgeons, Dublin, OH, USA.
Jihad KaoukDepartment of Urology, Cleveland Clinic, Cleveland, OH, USA.
Vipul PatelDepartment of Urology, Florida Celebration Health, Kissimmee, FL, USA.
Isaac Yi KimDepartment of Urology, Rutgers Cancer Center of New Jersey, New Brunswick, NJ, USA.
James PorterDepartment of Urology, Swedish Medical Center, Seattle, WA, USA.
Jim C HuWeill Cornell Medicine, New York, NY, USA.
University of California, Irvine · USAdventHealth Celebration · USCleveland Clinic · USCornell University · USOhioHealth · USRutgers, The State University of New Jersey · USSwedish Medical Center · USThe University of Texas MD Anderson Cancer Center · USThe University of Texas Medical Branch at Galveston · USUniversity of Pennsylvania · USUniversity of Rochester · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication, part of funding information was missed.

Identifiers

PMID31332511
OpenAlexW2963656708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.